SOD2 and Alzheimer disease: Overall, our current and previous data showing that the reduction of Sod2 activity in younger mice accelerated oxidative damage and hAPP/Aβ-related pathology supports the hypothesis that decreased Sod2 activity (and hence, increased O2•−) contributes to neuronal deterioration and impairment in AD.